Mashfiqur R. Khan, PhD

Mashfiqur R. Khan is a Manager in the Antitrust and Competition Practice. He has significant experience in economic analysis of competition, including merger analysis and damages estimation. He has worked on matters involving the agricultural, biotechnology, chemical, electronics, information technology, healthcare, and retail industries. In matters involving merger cases, Dr. Khan has supported experts in analyzing horizontal and vertical theories of harm as well as proposed or potential structural remedies. He has extensive experience working with plaintiffs’ counsel as well as with attorneys from the Federal Trade Commission.

Before joining Bates White, Dr. Khan taught undergraduate courses in Principles of Microeconomics and Labor Economics at Tulane University and at Boston College. His research is focused in the areas of labor economics and applied econometrics.

PhD, Economics, Boston College

MA, Economics, New York University

BSS, Economics, University of Dhaka

• Supported the expert in a Canadian class action litigation on behalf of plaintiffs who allege that Amazon and third-party sellers agreed on a most favored nation (MFN) provision that prohibits third-party sellers from offering their products on platforms other than Amazon at prices that are lower than the prices they charge on Amazon. 
• On behalf of Change Healthcare in its proposed $13.8 billion merger with UnitedHealth Group, supported the merging parties’ advocacy efforts and subsequent preparation for a challenge by the Department of Justice (DOJ). 
• Supported the expert in advising client being acquired in an information technology merger, providing evidence showing that the merging firms’ product portfolios were largely complementary and also rebutting vertical theories of harm investigated by antitrust authorities of various governments.
• Worked with the expert to assist Rite Aid in clearing its acquisition of Bartell Drugs before the Federal Trade Commission and the Washington State Attorney General’s office. 
• On behalf of several direct action plaintiffs that include large electronic component distributors and contract manufacturers, including Avent, supported the expert in submitting a rebuttal report in In re Capacitors Antitrust Litigation. A California federal jury returned a verdict for Avnet in the amount of $89.2 million.
• Supported the expert on behalf of defendants in litigation brought by the Federal Trade Commission to enjoin the proposed merger of Jefferson Health with Albert Einstein Healthcare Network. Evaluated the market definition and competitive effects, and analyzed the inpatient general acute care services market to evaluate the likely competitive effects of the merger.